Enteropeptidase (Recombinant)

Recombinant Protein · expressed in HEK293
Citation tracking pending
Recombinant human Enteropeptidase (TMPRSS15, UniProt P98073), expressed in HEK293 cells. Suited for trypsinogen activation assays, serine protease inhibitor screens, and antibody validation studies.
Expression system
HEK293
Cat. #
REC-Enteropeptidase

In stock

SKU
REC-Enteropeptidase
$498.00

Target Overview

Enteropeptidase (UniProt P98073; gene TMPRSS15) is a type II transmembrane serine protease expressed on the brush border of the duodenal epithelium. The full-length human protein spans 1,019 amino acids and is classified under EC 3.4.21.9. Its defining biochemical role is the highly specific cleavage of the trypsinogen activation peptide at the sequence Asp-Asp-Asp-Asp-Lys↓Ile, releasing active trypsin from trypsinogen. This single proteolytic event initiates a cascade that activates the full suite of pancreatic serine and metallo-proteases, including chymotrypsinogen, procarboxypeptidases, and proelastases. This recombinant is produced in HEK293 cells, an expression system that supports the post-translational processing — including disulfide bond formation and glycosylation — expected for a human type II transmembrane protease. The catalytic light chain, which carries the serine protease domain, is the enzymatically active component relevant to substrate cleavage assays. In the laboratory, this recombinant is used primarily in three contexts. First, it serves as an active enzyme source for trypsinogen-to-trypsin conversion assays, enabling kinetic characterisation (Km, kcat) under defined conditions. Second, because enteropeptidase is stringently selective for its polyaspartyl-lysine recognition sequence, it is widely used as a processing protease to remove affinity tags from recombinant fusion proteins without non-specific cleavage. Third, it functions as a positive control antigen for antibody validation: researchers using the matched Triple Point Biologics antibody (SKU: RP-Enteropeptidase) can confirm specificity by Western blot or IHC using this recombinant as a well-characterised standard. Species reactivity is validated for human.

Background

Enteropeptidase occupies a regulatory apex in digestive physiology. By converting trypsinogen to trypsin at the duodenal brush border, it controls the timed release of protease activity within the intestinal lumen — a safeguard against premature activation of pancreatic zymogens that would otherwise cause autodigestion. The enzyme is anchored to the apical membrane via a single-pass transmembrane domain, with its serine protease light chain exposed to the lumen and connected to a mosaic heavy chain by a disulfide bond. The heavy chain contains several structural modules — a low-density lipoprotein receptor class A domain, multiple CUB domains, and a MAM domain — that are implicated in correct trafficking, membrane anchoring, and substrate engagement. In basic research, TMPRSS15 loss-of-function has been studied as a model of congenital enteropeptidase deficiency, a rare autosomal recessive disorder characterised by failure to thrive, hypoproteinaemia, and oedema in neonates — a phenotype that directly illustrates the enzyme's non-redundant role in intestinal proteolytic activation. Recombinant enteropeptidase is used in published studies to reconstitute this activation cascade in vitro, allowing researchers to probe how individual sequence variants affect catalytic efficiency. Beyond digestive biology, proteomic surveys have detected TMPRSS15 among differentially expressed or circulating proteins in disease-associated cohorts. Canny et al. (2025) identified enteropeptidase among proteins evaluated in proteomic analyses of COVID-19-associated secondary hemophagocytic lymphohistiocytosis (sHLH), a severe hyperinflammatory syndrome, positioning it as a candidate biomarker in this context (PMID: 39888602). Such proteomic studies rely on well-characterised recombinant standards — exactly the use case this reagent addresses — to confirm protein identity and quantify assay signal. Enteropeptidase's exquisite selectivity for the Asp₄-Lys motif has also made it a standard reagent in recombinant protein production workflows. Researchers routinely engineer this recognition sequence between an affinity tag and their protein of interest, then use recombinant enteropeptidase to cleave the tag under mild conditions, leaving minimal extra residues on the target protein. This application is well established across structural biology, biochemistry, and cell biology laboratories. The availability of a HEK293-expressed recombinant with human sequence fidelity makes this product particularly suited to studies where glycosylation state or domain integrity may influence cleavage kinetics or downstream assay results.

Applications

  • Trypsinogen-to-trypsin activation assay: measurement of Km and kcat under defined pH and ionic strength conditions
  • Serine protease inhibitor IC50 determination using chromogenic or fluorogenic substrate read-outs
  • Affinity tag removal from recombinant fusion proteins engineered with an Asp-Asp-Asp-Asp-Lys cleavage site
  • Antibody specificity validation by Western blot using recombinant protein as a defined positive control (pair with Triple Point Biologics SKU: RP-Enteropeptidase)
  • Antibody validation by IHC using recombinant protein as an antigen standard
  • Substrate specificity profiling by mass spectrometry to map P-site preferences of the enteropeptidase catalytic domain
  • Proteomic calibration standard for quantitative detection of TMPRSS15 in biological matrix studies

References

  1. Canny SP et al. Proteomic Analyses in COVID-19-Associated Secondary Hemophagocytic Lymphohistiocytosis. Crit Care Explor. 2025. doi:10.1097/CCE.0000000000001203 PMID: 39888602
  2. Canny SP et al. Identification of biomarkers for COVID-19 associated secondary hemophagocytic lymphohistiocytosis. bioRxiv. 2024. doi:10.1101/2024.08.13.607855 PMID: 39185173
  3. Kendall KM et al. The relationship between schizophrenia polygenic scores, blood-based proteins and psychosis diagnosis in the UK Biobank. Schizophrenia (Heidelb). 2026. doi:10.1038/s41537-025-00725-8 PMID: 41535306
  4. Lokanc S et al. Gene alterations in inborn errors of immunity and their presence in cancers: Implications for oncogenesis, progression, and outcomes. Hum Immunol. 2026. doi:10.1016/j.humimm.2026.111671 PMID: 41616493
  5. Wang HF et al. Involvement of circRNA Regulators MBNL1 and QKI in the Progression of Esophageal Squamous Cell Carcinoma. Cancer Control. 2024. doi:10.1177/10732748241257142 PMID: 38769028

Additional Specifications

Storage Buffer 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol
Endotoxin Level <0.1 EU/µg by LAL
Purity (%) >90% by SDS-PAGE
Expression System HEK293
Subcellular Localization Type II transmembrane; small intestine brush border

Frequently Asked Questions

What molecular weight band should I expect for recombinant Enteropeptidase on SDS-PAGE or Western blot?

The catalytic light chain of human enteropeptidase — the enzymatically active serine protease domain — runs at approximately 35–40 kDa under reducing SDS-PAGE conditions. The full-length protein (1,019 aa, UniProt P98073) has a predicted MW of ~116 kDa, but the recombinant is produced as the processed light chain fragment rather than the intact single-pass transmembrane form. Because the protein is expressed in HEK293 cells and carries N-linked glycosylation, the apparent MW on gel typically runs slightly higher than the sequence-predicted value. Confirm identity with our matched antibody RP-Enteropeptidase.

What processing form is the Triple Point Biologics recombinant Enteropeptidase — full-length or catalytic light chain?

This recombinant corresponds to the catalytic light chain of human enteropeptidase (EC 3.4.21.9), which carries the serine protease domain responsible for substrate cleavage. The full-length TMPRSS15 protein is a type II transmembrane protease; the light chain is the soluble, enzymatically active fragment released after endogenous processing. Expression in HEK293 cells supports disulfide bond formation critical for proper folding of this domain. Researchers planning structural or binding studies requiring the full ectodomain, including the heavy chain, should note that this product is not the full-length transmembrane form.

What substrate does recombinant Enteropeptidase cleave and what sequence should I use for activity assays?

Enteropeptidase cleaves with high specificity after the pentapeptide sequence Asp-Asp-Asp-Asp-Lys (DDDDK↓), making Gly-Asp-Asp-Asp-Asp-Lys-β-naphthylamide (Gly-(Asp)4-Lys-βNA) the standard fluorogenic substrate for activity assays. For cleavage of trypsinogen, the natural substrate, the enzyme recognizes the DDDDK↓Ile junction in the activation peptide. Synthetic DDDDK-containing peptide substrates or fusion-tag removal applications (e.g., releasing His-tagged proteins after DDDDK cleavage) are the most common lab uses. Monitor fluorogenic substrate cleavage at excitation ~335 nm / emission ~410 nm for a straightforward continuous activity readout.

What buffer conditions work best for Enteropeptidase activity assays, and does the storage buffer interfere?

Enteropeptidase activity assays are routinely run in 50 mM Tris-HCl pH 7.5–8.0, 150 mM NaCl, with Ca²⁺ ions (1–5 mM CaCl₂) often included to support serine protease stability. The storage buffer for this recombinant — 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol — is fully compatible; glycerol at ≤1% final concentration in the reaction does not significantly inhibit activity at typical working dilutions. Avoid reducing agents such as DTT or β-mercaptoethanol above 1 mM, as they can disrupt the disulfide bonds required for the light chain's active conformation. pH optimum is 7.5–8.0.

What starting concentration of recombinant Enteropeptidase should I use for a trypsinogen activation or substrate cleavage assay?

For fluorogenic peptide substrate assays (e.g., Gly-(Asp)4-Lys-βNA), a starting concentration of 1–10 nM recombinant Enteropeptidase in a 50–100 µL reaction is a reasonable titration range. For trypsinogen activation assays, 0.1–1 µg enzyme per 10–50 µg trypsinogen is a common starting ratio; optimize based on your trypsinogen source and desired activation kinetics. Because specific activity can vary with storage history, always run a substrate titration on the first use of a new aliquot. Spin briefly at 10,000 × g before opening to collect any condensate from freeze-thaw.

Can I use recombinant Enteropeptidase as a positive control for Western blot with the RP-Enteropeptidase antibody?

Yes — this recombinant is the most direct positive control for the matched RP-Enteropeptidase rabbit polyclonal antibody (SKU: RP-Enteropeptidase). Because both products come from the same TPB workflow, antigen–antibody compatibility is confirmed. Load 50–200 ng of recombinant per lane under reducing conditions; this should yield a clean band at ~35–40 kDa (glycosylated light chain) detectable with a standard HRP-secondary at 1:5,000–1:10,000 dilution. This loading range avoids oversaturation while remaining well above the antibody's detection threshold, giving you a reliable size reference alongside endogenous samples from duodenal lysates.

How much recombinant Enteropeptidase should I load as a positive control and what band will RP-Enteropeptidase antibody detect?

Load 100–200 ng per lane for a robust positive control signal. The RP-Enteropeptidase antibody will detect the catalytic light chain at ~35–40 kDa (apparent MW under reducing SDS-PAGE, shifted slightly above sequence-predicted due to glycosylation from HEK293 expression). If you are also running duodenal epithelial cell lysate alongside, the same band should align. For lower-abundance samples where you need a faint positive control to avoid obscuring nearby bands, 50 ng is generally still detectable. Transfer efficiency for this MW range is reliable on standard PVDF at 100 V/1 h; no special transfer conditions are required.

How should I store recombinant Enteropeptidase and what is its shelf life after thawing?

Store at -20°C in single-use aliquots as supplied. The storage buffer — 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol — is formulated to maintain stability through long-term frozen storage, with shelf life of at least 12 months from the date of manufacture when stored correctly. Once thawed, keep on ice and use within the same working session; do not refreeze. Repeated freeze-thaw cycles cause measurable loss of specific activity for serine proteases and should be avoided. If your experiment requires multiple uses, aliquot to smaller volumes upon first receipt before freezing. Do not store at 4°C long-term.

Validation imagery coming soon

Western blot validation figures for REC-Enteropeptidase will be published here as they are produced in-house.

If you would like to see existing validation data for this antibody before publication, request a sample copy.

  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →